Ensuring GCP Compliance: A CRC’s Responsibility at the Site Level

Understanding GCP from a Site Perspective

Good Clinical Practice (GCP) is a cornerstone of ethical, quality-driven clinical research. While sponsors and CROs define overarching compliance frameworks, it’s the Clinical Research Coordinators (CRCs) who operationalize them at the site level. As frontline executors of study protocols, CRCs are responsible for embedding GCP into daily workflows—ranging from informed consent to data handling and source documentation.

According to ICH E6(R2), GCP compliance ensures that the rights, safety, and well-being of subjects are protected and that the trial data is credible. This article outlines practical steps CRCs take to uphold GCP across key areas of site operations, illustrated with examples from academic and industry-sponsored settings.

Ensuring Informed Consent is GCP Compliant

The informed consent process is a critical component of ethical compliance. CRCs must ensure:

• ✅ The most current IRB/EC-approved ICF version is used.
• ✅ Subjects are given adequate time to ask questions and decide.
• ✅ The PI or a qualified sub-investigator is present during consent discussions.
• ✅ Signed forms are filed correctly in both the subject binder and the Investigator Site File (ISF).

CRCs also check that translations are available for non-English speaking subjects and that assent forms are used for minors. Re-consenting is tracked when new versions are issued. Any deviation—such as consent taken after procedures start—must be reported and justified.

Source Documentation and ALCOA+ Principles

Accurate and complete source documentation underpins GCP compliance. CRCs are responsible for ensuring that all data is:

• ✅ Attributable, Legible, Contemporaneous, Original, and Accurate (ALCOA).
• ✅ Supported by source documents that match entries in the CRF or EDC system.
• ✅ Updated with appropriate audit trails for corrections.

For example, if a visit occurs outside the protocol window, the CRC must document the reason, note any impact on endpoints, and inform the sponsor. Electronic data entries must reflect real-time inputs with signature logs intact.

To explore real-world ALCOA+ deviations in audits, visit PharmaGMP: GMP Case Studies on Blockchain.

Maintaining Protocol Adherence and Deviation Control

Protocol adherence is a measurable aspect of site compliance. CRCs implement this by:

• ✅ Training staff on visit procedures and assessment requirements.
• ✅ Scheduling subject visits per protocol-specified intervals.
• ✅ Logging and escalating all protocol deviations.

Deviation logs should include root cause, impact assessment, and corrective/preventive actions (CAPAs). CRCs work with the PI and sponsor to document serious breaches (e.g., unblinded dosing errors) and notify the IRB if needed. This practice reinforces transparency and audit readiness.

Site Training, Delegation, and Oversight Logs

CRCs help maintain oversight by managing delegation logs and training records. Best practices include:

• ✅ Ensuring all team members are listed on the delegation log with role-specific tasks.
• ✅ Retaining GCP training certificates and protocol-specific training logs.
• ✅ Updating logs when roles change or new staff are onboarded.

Failure to maintain accurate logs is a common inspection finding. CRCs ensure that only qualified personnel perform study procedures, in line with GxP compliance expectations.

Monitoring Visit Preparation and Audit Readiness

Monitoring visits are essential checkpoints for site GCP adherence. CRCs must:

• ✅ Ensure source and regulatory documents are up to date and accessible.
• ✅ Prepare open query logs and deviation summaries.
• ✅ Participate actively in follow-up and CAPA implementation.

Sites with strong CRC involvement show fewer repeat findings across monitoring visits. Audit readiness also involves organizing the ISF, maintaining training logs, and confirming that key decisions are documented appropriately.

Conclusion

GCP compliance is not achieved by checklists alone; it requires the consistent application of quality and ethics principles in daily trial execution. CRCs are instrumental in translating these principles into action. By managing consent processes, documentation, training, monitoring, and protocol adherence, they create a compliance-focused site culture that supports both patient safety and regulatory success.

References:

• FDA: A Risk-Based Approach to Monitoring
• ICH E6(R2): Good Clinical Practice
• PharmaValidation: GxP Blockchain Templates